Global Medical Grade Honey Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Medical Grade Honey Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Medical Grade Honey market finds that the global Medical Grade Honey market reached a value of USD 57.66 million in 2022. It’s expected that the market will achieve USD 92.18 million by 2028, exhibiting a CAGR of 8.13% during the forecast period.

Medical Grade Honey Market Challenges

Medical Grade Honey belongs to the category of drugs, and there are strict regulatory laws for drugs in various countries. For example, in China’s Drug Administration Law of the People’s Republic of China, the following conditions should be met for engaging in drug production activities:
Have pharmacy technicians, engineering technicians
and corresponding skilled workers who have been qualified according to law;
Having workshops, facilities and sanitary environment suitable for the production of medicines;
It has institutions, personnel and necessary equipment that can conduct quality management and quality inspection of the drugs produced;
There are rules and regulations to ensure the quality of drugs, and they comply with the requirements of the drug production quality management standards formulated by the drug regulatory department of the State Council in accordance with this law.

In addition, the pharmaceutical industry is among the industries with higher environmental regulation requirements. With the increasing attention to environmental protection issues, countries have formulated stricter environmental standards and norms, and carried out relevant environmental supervision work. In the future, if governments around the world issue new laws and regulations to further strengthen various types of supervision over the pharmaceutical industry, the production cost of Medical Grade Honey will be higher, which may have a certain impact on the profitability of Medical Grade Honey producers.

Region Overview:

From 2023-2028, Australia & New Zealand is estimated to witness robust growth prospects.

Company Overview:

The top three companies are Comvita, Manuka Health and Melcare Biomedical (NZ Mānuka Group) with the revenue market share of 20.40%, 14.24% and 10.11% in 2020.

Comvita is a New Zealand health products company whose main products are honey, etc.

Manuka Health is a New Zealand company whose main products are bee products.

Segmentation Overview:

Among different product types, UMF 10+ segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Ulcers segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Medical Grade Honey market covered in Chapter 3:

Manuka Health
ManukaMed
Australia's Manuka
Mossop's Honey
Comvita
Melcare Biomedical (NZ Mānuka Group)
New Zealand Honey Co.
Watson & Son (Oha Honey)

In Chapter 4 and Chapter 14.2, on the basis of types, the Medical Grade Honey market from 2018 to 2029 is primarily split into:

UMF 10+
UMF 15+
UMF 20+
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Medical Grade Honey market from 2018 to 2029 covers:

Ulcers
Surgical Wounds
Traumatic Wounds
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)